Publications by authors named "Parameswaran N Hari"

71Publications

Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma.

Biol Blood Marrow Transplant 2020 Dec 11;26(12):2229-2236. Epub 2020 Sep 11.

Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Blood and Marrow Transplant & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Milwaukee Campus, Milwaukee, Wisconsin. Electronic address:

View Article and Find Full Text PDF
December 2020

Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challenges.

Bone Marrow Transplant 2021 Jan 7;56(1):9-19. Epub 2020 Aug 7.

BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.

View Article and Find Full Text PDF
January 2021

Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients.

Biol Blood Marrow Transplant 2020 Nov 24;26(11):2011-2017. Epub 2020 Jul 24.

Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Blood and Marrow Transplant & Cellular Therapy Program, Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Milwaukee Campus, Milwaukee, Wisconsin.

View Article and Find Full Text PDF
November 2020

Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2020 Oct 9;26(10):1876-1885. Epub 2020 Jul 9.

Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Blood and Marrow Transplant & Cellular Therapy Program, Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Milwaukee Campus, Milwaukee, Wisconsin. Electronic address:

View Article and Find Full Text PDF
October 2020

Letter to the Editor Regarding "Diagnostic Considerations for COVID-19 in Recipients of Allogeneic Hematopoietic Cell Transplantation".

Biol Blood Marrow Transplant 2020 09 23;26(9):e241-e242. Epub 2020 Jun 23.

Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article and Find Full Text PDF
September 2020

Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation.

Biol Blood Marrow Transplant 2020 09 17;26(9):1670-1678. Epub 2020 Jun 17.

BMT & Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Center of International Blood and Marrow Transplant Research, Milwaukee, Wisconsin; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article and Find Full Text PDF
September 2020

Clinical activity of ibrutinib in classical Hodgkin lymphoma relapsing after allogeneic stem cell transplantation is independent of tumor BTK expression.

Br J Haematol 2020 Jul 16;190(2):e98-e101. Epub 2020 May 16.

BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article and Find Full Text PDF
July 2020

Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic Transplantation.

Clin Lymphoma Myeloma Leuk 2020 06 27;20(6):407-414. Epub 2020 Jan 27.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article and Find Full Text PDF
June 2020

Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.

Biol Blood Marrow Transplant 2020 05 23;26(5):893-901. Epub 2020 Jan 23.

Blood and Marrow Transplant & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article and Find Full Text PDF
May 2020

Gut microbiome and CAR-T therapy.

Exp Hematol Oncol 2019 19;8:31. Epub 2019 Nov 19.

2Division of Hematology/Oncology, Medical College of Wisconsin (MCW), Milwaukee, WI USA.

View Article and Find Full Text PDF
November 2019

Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease.

Leuk Lymphoma 2020 04 25;61(4):869-874. Epub 2019 Nov 25.

Division of Hematology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article and Find Full Text PDF
April 2020

Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 08 6;25(8):1689-1694. Epub 2019 Apr 6.

Blood & Marrow Transplantation and Cellular Therapy Program, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article and Find Full Text PDF
August 2019